Compliance with Guidelines on Thromboprophylaxis for Acutely Admitted Medical Patients
Introduction The risk of venous thromboembolism (VTE) is increased by more than 100-fold among hospitalised medical patients compared to subjects in the community. The Danish Council for the Use of Expensive Hospital Medicines has published national guidelines on thromboprophylaxis (TP) in which the...
Saved in:
Published in | Advances in therapy Vol. 35; no. 11; pp. 1873 - 1883 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Cheshire
Springer Healthcare
01.11.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Introduction
The risk of venous thromboembolism (VTE) is increased by more than 100-fold among hospitalised medical patients compared to subjects in the community. The Danish Council for the Use of Expensive Hospital Medicines has published national guidelines on thromboprophylaxis (TP) in which the risks of VTE and bleeding are balanced. We wanted to investigate the proportion of acutely admitted medical patients for whom thromboprophylaxis was indicated and to what extent the guidelines were followed.
Methods
Data from patients hospitalised at two medical wards were screened. We registered the proportion of patients for whom mechanical or pharmacologic TP (MTP and PTP, respectively) was indicated and whether national guidelines were followed. All data extraction and analyses were performed retrospectively.
Results
After exclusion criteria were applied, 340 cases remained. PTP was indicated in 26 patients (7.6%) but only 4 patients were treated besides 12 patients who were already in anticoagulant treatment at submission. Conversely, 8/306 patients, in whom TP was not indicated, were started on PTP. MTP was indicated in 8/340 patients (2.4%) but therapy was not initiated in any of them. The majority (320/340, 94.1%) of cases was managed in accordance with existing guidelines. However, this high proportion was mainly explained by the large number of untreated patients, where TP was not indicated.
Conclusion
A large proportion of hospitalised medical patients was managed in conflict with national guidelines. A systematic approach to TP in patients with acute medical illness should be implemented.
Plain Language Summary
Plain language summary available for this article. |
---|---|
AbstractList | Introduction
The risk of venous thromboembolism (VTE) is increased by more than 100-fold among hospitalised medical patients compared to subjects in the community. The Danish Council for the Use of Expensive Hospital Medicines has published national guidelines on thromboprophylaxis (TP) in which the risks of VTE and bleeding are balanced. We wanted to investigate the proportion of acutely admitted medical patients for whom thromboprophylaxis was indicated and to what extent the guidelines were followed.
Methods
Data from patients hospitalised at two medical wards were screened. We registered the proportion of patients for whom mechanical or pharmacologic TP (MTP and PTP, respectively) was indicated and whether national guidelines were followed. All data extraction and analyses were performed retrospectively.
Results
After exclusion criteria were applied, 340 cases remained. PTP was indicated in 26 patients (7.6%) but only 4 patients were treated besides 12 patients who were already in anticoagulant treatment at submission. Conversely, 8/306 patients, in whom TP was not indicated, were started on PTP. MTP was indicated in 8/340 patients (2.4%) but therapy was not initiated in any of them. The majority (320/340, 94.1%) of cases was managed in accordance with existing guidelines. However, this high proportion was mainly explained by the large number of untreated patients, where TP was not indicated.
Conclusion
A large proportion of hospitalised medical patients was managed in conflict with national guidelines. A systematic approach to TP in patients with acute medical illness should be implemented.
Plain Language Summary
Plain language summary available for this article. INTRODUCTIONThe risk of venous thromboembolism (VTE) is increased by more than 100-fold among hospitalised medical patients compared to subjects in the community. The Danish Council for the Use of Expensive Hospital Medicines has published national guidelines on thromboprophylaxis (TP) in which the risks of VTE and bleeding are balanced. We wanted to investigate the proportion of acutely admitted medical patients for whom thromboprophylaxis was indicated and to what extent the guidelines were followed.METHODSData from patients hospitalised at two medical wards were screened. We registered the proportion of patients for whom mechanical or pharmacologic TP (MTP and PTP, respectively) was indicated and whether national guidelines were followed. All data extraction and analyses were performed retrospectively.RESULTSAfter exclusion criteria were applied, 340 cases remained. PTP was indicated in 26 patients (7.6%) but only 4 patients were treated besides 12 patients who were already in anticoagulant treatment at submission. Conversely, 8/306 patients, in whom TP was not indicated, were started on PTP. MTP was indicated in 8/340 patients (2.4%) but therapy was not initiated in any of them. The majority (320/340, 94.1%) of cases was managed in accordance with existing guidelines. However, this high proportion was mainly explained by the large number of untreated patients, where TP was not indicated.CONCLUSIONA large proportion of hospitalised medical patients was managed in conflict with national guidelines. A systematic approach to TP in patients with acute medical illness should be implemented. Plain language summary available for this article. The risk of venous thromboembolism (VTE) is increased by more than 100-fold among hospitalised medical patients compared to subjects in the community. The Danish Council for the Use of Expensive Hospital Medicines has published national guidelines on thromboprophylaxis (TP) in which the risks of VTE and bleeding are balanced. We wanted to investigate the proportion of acutely admitted medical patients for whom thromboprophylaxis was indicated and to what extent the guidelines were followed. Data from patients hospitalised at two medical wards were screened. We registered the proportion of patients for whom mechanical or pharmacologic TP (MTP and PTP, respectively) was indicated and whether national guidelines were followed. All data extraction and analyses were performed retrospectively. After exclusion criteria were applied, 340 cases remained. PTP was indicated in 26 patients (7.6%) but only 4 patients were treated besides 12 patients who were already in anticoagulant treatment at submission. Conversely, 8/306 patients, in whom TP was not indicated, were started on PTP. MTP was indicated in 8/340 patients (2.4%) but therapy was not initiated in any of them. The majority (320/340, 94.1%) of cases was managed in accordance with existing guidelines. However, this high proportion was mainly explained by the large number of untreated patients, where TP was not indicated. A large proportion of hospitalised medical patients was managed in conflict with national guidelines. A systematic approach to TP in patients with acute medical illness should be implemented. Plain language summary available for this article. |
Author | Madsen, Søren M. Freund, Nanna Sabroe, Jonas E. Bytzer, Peter |
Author_xml | – sequence: 1 givenname: Nanna orcidid: 0000-0001-8407-6894 surname: Freund fullname: Freund, Nanna email: nannafreund@gmail.com organization: Department of Medicine, Zealand University Hospital Køge – sequence: 2 givenname: Jonas E. surname: Sabroe fullname: Sabroe, Jonas E. organization: Department of Medicine, Zealand University Hospital Køge – sequence: 3 givenname: Peter surname: Bytzer fullname: Bytzer, Peter email: pmby@regionsjaelland.dk organization: Department of Medicine, Zealand University Hospital Køge, Department of Clinical Medicine, University of Copenhagen – sequence: 4 givenname: Søren M. surname: Madsen fullname: Madsen, Søren M. email: smma@regionsjaelland.dk organization: Department of Medicine, Zealand University Hospital Køge |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30367365$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kL1OxDAQhC0EguPgAWiQS5qA1_lxXJ5OcCCBoABEZznJhjNK7MNOBHl7jA4oKVZb7Mxo5zsku9ZZJOQE2DkwJi4C8JTnCYMyYSWHZNohMyiLPInDd8mMiQwSnpYvB-QwhDfGOBN5uU8OUpYWIi3yGXleun7TGW1rpB9mWNPVaBrsjMVAnaWPa-_6ym2826ynTn-aQFvn6aIeB-wmumh6MwzY0DtsTK07-qAHg3YIR2Sv1V3A4589J09Xl4_L6-T2fnWzXNwmdZplQwIVA1blHHIhdVMLxrNSFAWilFIzIVqEgpdS8oy3qUw1okbOQELVCJSxxZycbXPjh-8jhkH1JtTYddqiG4PiwAsJooxt5wS20tq7EDy2auNNr_2kgKlvnGqLU0Wc6hunmqLn9Cd-rHps_hy__KKAbwUhnuwrevXmRm9j5X9SvwDnWIJN |
CitedBy_id | crossref_primary_10_1016_j_amjmed_2019_08_051 |
Cites_doi | 10.1378/chest.11-2404 10.1378/chest.10-1944 10.1056/NEJM199909093411103 10.1002/14651858.CD008201.pub2 10.1160/TH14-03-0239 10.1111/j.1538-7836.2010.04044.x 10.1111/j.1572-0241.2008.02052.x 10.1378/chest.07-0430 10.1378/chest.11-2296 10.1038/ajg.2009.727 10.1378/chest.09-3081 10.1634/theoncologist.2015-0361 10.1007/s00228-005-0944-3 10.1200/JOP.2015.004473 10.1378/chest.11-2297 10.1002/14651858.CD003747.pub4 10.1160/TH05-06-0385 |
ContentType | Journal Article |
Copyright | Springer Healthcare Ltd., part of Springer Nature 2018 |
Copyright_xml | – notice: Springer Healthcare Ltd., part of Springer Nature 2018 |
DBID | NPM AAYXX CITATION 7X8 |
DOI | 10.1007/s12325-018-0821-y |
DatabaseName | PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1865-8652 |
EndPage | 1883 |
ExternalDocumentID | 10_1007_s12325_018_0821_y 30367365 |
Genre | Journal Article |
GroupedDBID | --- -5E -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 23M 2J2 2JN 2JY 2KG 2KM 2VQ 30V 4.4 406 408 40D 40E 53G 5GY 5VS 67Z 6NX 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AAIAL AAIKX AAJKR AANXM AANZL AAPBV AARHV AARTL AATNV AAWCG AAWTL AAYFA AAYIU AAYQN AAYTO ABDZT ABFTV ABHLI ABJNI ABJOX ABKCH ABMNI ABNWP ABPLI ABQBU ABTKH ABTMW ABWBT ABXPI ACBMV ACBRV ACBYP ACGFS ACHXU ACIGE ACKNC ACMLO ACOKC ACSNA ACTTH ACVWB ADFZG ADHHG ADHIR ADINQ ADKPE ADMDM ADRFC ADURQ AEBTG AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFALF AFLOW AFNRJ AFWTZ AFZKB AGAYW AGDGC AGGBP AGJBK AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHKMG AHSBF AHYZX AIAKS AIIXL AILAN AJBLW AJDOV AJRNO ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR ANMIH ARMRJ AWSVR AXYYD B-. BA0 BGNMA CAG COF CS3 CSCUP DNIVK DPUIP EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FERAY FFXSO FIGPU FLLZZ FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 HF~ HG5 HG6 HMJXF HRMNR HZ~ IWAJR IXC IXD I~X I~Z J-C JBSCW JZLTJ KOV KPH LLZTM M4Y MA- MK0 NQJWS NU0 O9- O93 O9I OVD P2P P9S PF0 QOR QOS R89 R9I ROL RPX RSV S16 S1Z S27 S37 S3B SAP SDH SHX SISQX SMD SNE SNPRN SNX SOHCF SOJ SPKJE SRMVM SSLCW SV3 SZ9 SZN T13 TEORI TSG TSK TT1 TUC U2A U9L UG4 UNUBA UPIKM UTJUX UZXMN VC2 VDBLX VFIZW W48 WK8 Z45 Z7U Z7V Z7W Z81 Z82 Z83 Z84 Z87 ~A9 ~JE AACDK AASML AAYZH ABAKF ACAOD ACCOQ ACDTI ACZOJ AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU H13 NPM SJYHP ZMTXR AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c344t-1b010b521579adc70248766ee999a077fe162899242f393aeeae20191bd7e9303 |
IEDL.DBID | AGYKE |
ISSN | 0741-238X |
IngestDate | Fri Oct 25 00:40:31 EDT 2024 Thu Sep 12 17:00:01 EDT 2024 Wed Oct 16 00:47:03 EDT 2024 Sat Dec 16 12:03:55 EST 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | Pulmonary embolism Guideline adherence Hospitalization Preventive medicine Cardiology Heparin low-molecular-weight Venous thromboembolism |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c344t-1b010b521579adc70248766ee999a077fe162899242f393aeeae20191bd7e9303 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-8407-6894 |
PMID | 30367365 |
PQID | 2126917867 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_2126917867 crossref_primary_10_1007_s12325_018_0821_y pubmed_primary_30367365 springer_journals_10_1007_s12325_018_0821_y |
PublicationCentury | 2000 |
PublicationDate | 2018-11-01 |
PublicationDateYYYYMMDD | 2018-11-01 |
PublicationDate_xml | – month: 11 year: 2018 text: 2018-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Cheshire |
PublicationPlace_xml | – name: Cheshire – name: United States |
PublicationTitle | Advances in therapy |
PublicationTitleAbbrev | Adv Ther |
PublicationTitleAlternate | Adv Ther |
PublicationYear | 2018 |
Publisher | Springer Healthcare |
Publisher_xml | – name: Springer Healthcare |
References | Falck-Ytter, Francis, Johanson (CR12) 2012; 141 Kuderer, Culakova, Lyman, Francis, Falanga, Khorana (CR8) 2016; 21 Alikhan, Forster, Cohen (CR26) 2014 Gould, Garcia, Wren (CR13) 2012; 141 Mahé, Bergmann, d’Azémar, Vaissie, Caulin (CR24) 2005; 61 CR17 CR14 CR11 CR10 Kornbluth, Sachar (CR16) 2010; 105 Cohen, Alikhan, Arcelus (CR1) 2005; 94 Mahan, Liu, Turpie (CR7) 2014; 112 Decousus, Tapson, Bergmann (CR9) 2011; 139 Bergmann, Lloret-Linares, Rami (CR2) 1983; 2011 CR4 Lyman, Bohlke, Falanga (CR18) 2015; 11 CR6 Spyropoulos, Anderson, FitzGerald (CR5) 2011; 140 Sabroe (CR3) 2016; 178 Kahn, Lim, Dunn (CR20) 2012; 141 CR23 CR22 Barbar, Noventa, Rossetto (CR21) 2010; 8 Samama, Cohen, Darmon (CR25) 1999; 341 Kahn, Morrison, Cohen, Emed, Tagalakis, Roussin, Geerts (CR27) 2013 Piazza, Seddighzadeh, Goldhaber (CR19) 2007; 132 Nguyen, Sam (CR15) 2008; 103 AT Cohen (821_CR1) 2005; 94 821_CR22 MM Samama (821_CR25) 1999; 341 821_CR23 JE Sabroe (821_CR3) 2016; 178 NM Kuderer (821_CR8) 2016; 21 821_CR4 AC Spyropoulos (821_CR5) 2011; 140 821_CR6 S Barbar (821_CR21) 2010; 8 CE Mahan (821_CR7) 2014; 112 MK Gould (821_CR13) 2012; 141 GC Nguyen (821_CR15) 2008; 103 J-F Bergmann (821_CR2) 1983; 2011 Y Falck-Ytter (821_CR12) 2012; 141 821_CR11 821_CR10 GH Lyman (821_CR18) 2015; 11 G Piazza (821_CR19) 2007; 132 821_CR14 821_CR17 I Mahé (821_CR24) 2005; 61 A Kornbluth (821_CR16) 2010; 105 SR Kahn (821_CR27) 2013 R Alikhan (821_CR26) 2014 H Decousus (821_CR9) 2011; 139 SR Kahn (821_CR20) 2012; 141 |
References_xml | – ident: CR22 – volume: 141 start-page: e278S year: 2012 end-page: e325S ident: CR12 article-title: Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines publication-title: Chest doi: 10.1378/chest.11-2404 contributor: fullname: Johanson – volume: 140 start-page: 706 year: 2011 end-page: 714 ident: CR5 article-title: Predictive and associative models to identify hospitalized medical patients at risk for VTE publication-title: Chest doi: 10.1378/chest.10-1944 contributor: fullname: FitzGerald – ident: CR4 – ident: CR14 – volume: 2011 start-page: e528 issue: 40 year: 1983 end-page: e537 ident: CR2 article-title: Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): results obtained in France publication-title: Presse Med Paris Fr contributor: fullname: Rami – volume: 341 start-page: 793 year: 1999 end-page: 800 ident: CR25 article-title: A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients prophylaxis in medical patients with Enoxaparin Study Group publication-title: N Engl J Med doi: 10.1056/NEJM199909093411103 contributor: fullname: Darmon – ident: CR10 – year: 2013 ident: CR27 article-title: Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism publication-title: Cochrane Database Syst Rev. doi: 10.1002/14651858.CD008201.pub2 contributor: fullname: Geerts – ident: CR6 – volume: 112 start-page: 692 year: 2014 end-page: 699 ident: CR7 article-title: External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR) publication-title: Thromb Haemost doi: 10.1160/TH14-03-0239 contributor: fullname: Turpie – volume: 8 start-page: 2450 year: 2010 end-page: 2457 ident: CR21 article-title: A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score publication-title: J Thromb Haemost JTH doi: 10.1111/j.1538-7836.2010.04044.x contributor: fullname: Rossetto – volume: 103 start-page: 2272 year: 2008 end-page: 2280 ident: CR15 article-title: Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2008.02052.x contributor: fullname: Sam – ident: CR23 – volume: 132 start-page: 554 year: 2007 end-page: 561 ident: CR19 article-title: Double trouble for 2,609 hospitalized medical patients who developed deep vein thrombosis: prophylaxis omitted more often and pulmonary embolism more frequent publication-title: Chest doi: 10.1378/chest.07-0430 contributor: fullname: Goldhaber – volume: 141 start-page: e195S year: 2012 end-page: e226S ident: CR20 article-title: Prevention of VTE in Nonsurgical Patients publication-title: Chest doi: 10.1378/chest.11-2296 contributor: fullname: Dunn – volume: 105 start-page: 501 year: 2010 end-page: 523 ident: CR16 article-title: Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee publication-title: Am J Gastroenterol doi: 10.1038/ajg.2009.727 contributor: fullname: Sachar – volume: 94 start-page: 750 year: 2005 end-page: 759 ident: CR1 article-title: Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients publication-title: Thromb Haemost contributor: fullname: Arcelus – volume: 139 start-page: 69 year: 2011 end-page: 79 ident: CR9 article-title: Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators publication-title: Chest doi: 10.1378/chest.09-3081 contributor: fullname: Bergmann – ident: CR17 – volume: 178 start-page: 2 year: 2016 end-page: 5 ident: CR3 article-title: Madsen SM [Low molecular weight heparin as venous thromboembolism prophylaxis in hospitalized medical patients] publication-title: Ugeskr Laeger contributor: fullname: Sabroe – volume: 21 start-page: 861 year: 2016 end-page: 867 ident: CR8 article-title: A validated risk score for venous thromboembolism is predictive of cancer progression and mortality publication-title: Oncologist doi: 10.1634/theoncologist.2015-0361 contributor: fullname: Khorana – ident: CR11 – volume: 61 start-page: 347 year: 2005 end-page: 351 ident: CR24 article-title: Lack of effect of a low-molecular-weight heparin (nadroparin) on mortality in bedridden medical in-patients: a prospective randomised double-blind study publication-title: Eur J Clin Pharmacol doi: 10.1007/s00228-005-0944-3 contributor: fullname: Caulin – volume: 11 start-page: e442 year: 2015 end-page: e444 ident: CR18 article-title: Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update publication-title: J Oncol Pract doi: 10.1200/JOP.2015.004473 contributor: fullname: Falanga – volume: 141 start-page: e227S year: 2012 end-page: e277S ident: CR13 article-title: Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines publication-title: Chest doi: 10.1378/chest.11-2297 contributor: fullname: Wren – year: 2014 ident: CR26 article-title: Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction) publication-title: Cochrane Database Syst Rev. doi: 10.1002/14651858.CD003747.pub4 contributor: fullname: Cohen – volume: 132 start-page: 554 year: 2007 ident: 821_CR19 publication-title: Chest doi: 10.1378/chest.07-0430 contributor: fullname: G Piazza – volume: 11 start-page: e442 year: 2015 ident: 821_CR18 publication-title: J Oncol Pract doi: 10.1200/JOP.2015.004473 contributor: fullname: GH Lyman – volume: 139 start-page: 69 year: 2011 ident: 821_CR9 publication-title: Chest doi: 10.1378/chest.09-3081 contributor: fullname: H Decousus – volume: 140 start-page: 706 year: 2011 ident: 821_CR5 publication-title: Chest doi: 10.1378/chest.10-1944 contributor: fullname: AC Spyropoulos – year: 2014 ident: 821_CR26 publication-title: Cochrane Database Syst Rev. doi: 10.1002/14651858.CD003747.pub4 contributor: fullname: R Alikhan – volume: 141 start-page: e227S year: 2012 ident: 821_CR13 publication-title: Chest doi: 10.1378/chest.11-2297 contributor: fullname: MK Gould – ident: 821_CR22 – volume: 94 start-page: 750 year: 2005 ident: 821_CR1 publication-title: Thromb Haemost doi: 10.1160/TH05-06-0385 contributor: fullname: AT Cohen – volume: 21 start-page: 861 year: 2016 ident: 821_CR8 publication-title: Oncologist doi: 10.1634/theoncologist.2015-0361 contributor: fullname: NM Kuderer – ident: 821_CR10 – volume: 112 start-page: 692 year: 2014 ident: 821_CR7 publication-title: Thromb Haemost doi: 10.1160/TH14-03-0239 contributor: fullname: CE Mahan – ident: 821_CR14 – volume: 141 start-page: e278S year: 2012 ident: 821_CR12 publication-title: Chest doi: 10.1378/chest.11-2404 contributor: fullname: Y Falck-Ytter – ident: 821_CR23 – volume: 2011 start-page: e528 issue: 40 year: 1983 ident: 821_CR2 publication-title: Presse Med Paris Fr contributor: fullname: J-F Bergmann – volume: 8 start-page: 2450 year: 2010 ident: 821_CR21 publication-title: J Thromb Haemost JTH doi: 10.1111/j.1538-7836.2010.04044.x contributor: fullname: S Barbar – volume: 341 start-page: 793 year: 1999 ident: 821_CR25 publication-title: N Engl J Med doi: 10.1056/NEJM199909093411103 contributor: fullname: MM Samama – year: 2013 ident: 821_CR27 publication-title: Cochrane Database Syst Rev. doi: 10.1002/14651858.CD008201.pub2 contributor: fullname: SR Kahn – volume: 178 start-page: 2 year: 2016 ident: 821_CR3 publication-title: Ugeskr Laeger contributor: fullname: JE Sabroe – ident: 821_CR4 – ident: 821_CR6 – volume: 61 start-page: 347 year: 2005 ident: 821_CR24 publication-title: Eur J Clin Pharmacol doi: 10.1007/s00228-005-0944-3 contributor: fullname: I Mahé – volume: 141 start-page: e195S year: 2012 ident: 821_CR20 publication-title: Chest doi: 10.1378/chest.11-2296 contributor: fullname: SR Kahn – volume: 105 start-page: 501 year: 2010 ident: 821_CR16 publication-title: Am J Gastroenterol doi: 10.1038/ajg.2009.727 contributor: fullname: A Kornbluth – ident: 821_CR11 – ident: 821_CR17 – volume: 103 start-page: 2272 year: 2008 ident: 821_CR15 publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2008.02052.x contributor: fullname: GC Nguyen |
SSID | ssj0020758 |
Score | 2.2162468 |
Snippet | Introduction
The risk of venous thromboembolism (VTE) is increased by more than 100-fold among hospitalised medical patients compared to subjects in the... The risk of venous thromboembolism (VTE) is increased by more than 100-fold among hospitalised medical patients compared to subjects in the community. The... INTRODUCTIONThe risk of venous thromboembolism (VTE) is increased by more than 100-fold among hospitalised medical patients compared to subjects in the... |
SourceID | proquest crossref pubmed springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1873 |
SubjectTerms | Cardiology Endocrinology Internal Medicine Medicine Medicine & Public Health Oncology Original Research Pharmacology/Toxicology Rheumatology |
Title | Compliance with Guidelines on Thromboprophylaxis for Acutely Admitted Medical Patients |
URI | https://link.springer.com/article/10.1007/s12325-018-0821-y https://www.ncbi.nlm.nih.gov/pubmed/30367365 https://search.proquest.com/docview/2126917867 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEB7ygNJL2qav7WNRoeTQRktly5J93IRsQkvCHrJlezKSM4KQ1A6xDXV_fUd-7FK2PeRuS7Zm5O8bzcxngI9Wi8A56bjTgeMSEbl1seIuDIQTkQ1Mq8R0fqHOFvLrMlpuQbA6ushvJkNGsv1Qr3vdCPt9nZkXVA4Eb7Zht-873Z2e_vh2sgqzCATjTnxTcAKk5ZDL_Ncgf6PRBsXcSI-2qDN70nUClq1YoS82uZnUlZ1kvzelHB_wQk9hryehbNp5zTPYwnwfHp33afZ9OJh3gtbNIbtc92eVh-yAzddS181z-H7cVqR7z2H-RJed1l42y5fSsyKnm--Ln7agpydj3ppf1yUjjsymWV3hbcO8cG9FjJf12SI270ReyxewmJ1cHp_x_k8NPAulrLiwFNZZMkekE3OVaS-UppVCJPppvmjtUCgf2REfcGESGkSDxDwSYa80JoSiL2EnL3J8DSxGYW0sncpkKDMnLDojEyfRCNRZFI_g02Cx9K4T5EjX0st-SVNa0tQvadqM4MNg05S2jc-FmByLukzJcxRFqrHSI3jVGXs1nEd1HapoBJ8Hy6X9zi7_P9ebB139Fh4H3vRtV-M72Knua3xP9KayY_Ln2dHRxbj36zFsL4LpH0T09Hc |
link.rule.ids | 315,783,787,27936,27937,41093,41535,42162,42604,52123,52246 |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9QwEB3BVoJeKBQoSwsYCfUATYUTx06Oq6rtQrvVHrZoOVl2OpYQJUFNIhF-PeN8dFUKh94T2_GM895kZl4A3lnFQ-eEC5wKXSAQMbAukYGLQu54bEPTKjHNzuT0XHxexsu-j7scqt2HlGT7pl41uxH4-0Izr6gc8qC5D2si5DIcwdrk-OvJ4XWcRSiYdOqbPCBEWg7JzH8NchOObnHMW_nRFnaONmAxLLirNvm-X1d2P_v9l5bjHZ_oMTzqaSibdH7zBO5hvgkPZn2ifRN2552kdbPHFqsOrXKP7bL5Suy6eQpfDtqadO87zH_TZce1F87yxfSsyOnmq-KHLWj5ZM5L8-tbyYgls0lWV3jZMC_dWxHnZX2-iM07mdfyGZwfHS4OpkH_r4Ygi4SoAm4psLPEBWKVmotMeak0JSUiEVDzUSmHZCmK7YgRuCiNDKJB4h4ptxcKU8LR5zDKixxfAEuQW5sIJzMRicxxi86I1Ak0HFUWJ2N4P5hM_-wkOfRKfNlvqaYt1X5LdTOGt4NRNR0cnw0xORZ1qQmzJcWqiVRj2OqsfT2cx3UVyXgMHwbL6f5sl_-f6-Wdrn4DD6eL2ak-_XR2sg3roXeDtsdxB0bVVY2viOxU9nXv3H8APQn15g |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7BVqq48Civ5Wkk1APULU4cOzmuSreF0moPLVpOxs6OJURJqiaRCL-e8SbpCgoHxD2xY89Y3zeZmc8AL50WkffSc68jzyUicudTxX0cCS8SF9mlEtPRsTo4le_nyby_57Qaqt2HlGTX0xBUmop653zhd1aNb0QEQtFZUFeOBG-vw5oMwkgjWJvsfzrcu4y5CBHTTolTcEKn-ZDY_NMgv0LTFb55JVe6hKDpLfg8fHxXefJ1u6nddv7jN13H_1jdbbjZ01M26fzpDlzDYgPWj_oE_AZszjqp63aLnaw6t6ottslmKxHs9i583F3WqgefYuFfL9tvgqBWKLJnZUEvX5TfXElLITOf2e9fKkbsmU3ypsazlgVJ35q4MOvzSGzWyb9W9-B0uneye8D7Oxx4HktZc-Eo4HPEERKd2UWug4SaVgqRiKl9o7VHoULMR0zBx1lsES0SJ8mEW2jMCF_vw6goC3wILEXhXCq9ymUscy8ceiszL9EK1HmSjuHVYD5z3kl1mJUoc9hSQ1tqwpaadgwvBgMbOlAhS2ILLJvKEJYrimFTpcfwoLP85XAB73WskjG8Hqxo-jNf_X2uR__09HNYn72dmg_vjg8fw40oeMGy9fEJjOqLBp8SB6rds97PfwKUy_7K |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Compliance+with+Guidelines+on+Thromboprophylaxis+for+Acutely+Admitted+Medical+Patients&rft.jtitle=Advances+in+therapy&rft.au=Freund%2C+Nanna&rft.au=Sabroe%2C+Jonas+E&rft.au=Bytzer%2C+Peter&rft.au=Madsen%2C+S%C3%B8ren+M&rft.date=2018-11-01&rft.eissn=1865-8652&rft.volume=35&rft.issue=11&rft.spage=1873&rft_id=info:doi/10.1007%2Fs12325-018-0821-y&rft_id=info%3Apmid%2F30367365&rft.externalDocID=30367365 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0741-238X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0741-238X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0741-238X&client=summon |